Search results for " immunology"

showing 10 items of 1841 documents

529. PROPROTEIN CONVERTASE 6 PLAYS A CRITICAL ROLE IN MODULATING THE HUMAN ENDOMETRIAL EPITHELIUM FOR RECEPTIVITY AND IMPLANTATION

2009

Successful embryo implantation is an important step in establishing pregnancy, requiring a healthy embryo and a receptive endometrium. Establishment of endometrial receptivity involves morphological and physiological changes initially in the endometrial epithelium, but the underlying molecular mechanisms are not fully understood. We have previously demonstrated that proprotein convertase 5/6 (PC6), a member of the proprotein convertase (PC) family, is up-regulated in the endometrium specifically at implantation in association with epithelial differentiation, in the human and monkey. PCs convert a range of precursor proteins of important functions into their bioactive forms; they are thus r…

medicine.medical_specialtyGene knockdownReproductive immunologyEmbryo cultureEmbryoReproductive technologyTransfectionBiologyEndometriumProprotein convertaseAndrologyEndocrinologymedicine.anatomical_structureEndocrinologyReproductive MedicineInternal medicineGeneticsmedicineAnimal Science and ZoologyMolecular BiologyDevelopmental BiologyBiotechnologyReproduction, Fertility and Development
researchProduct

Factors influencing vaccine uptake in Germany.

2001

While vaccines have virtually eliminated many infectious diseases in Germany, vaccination coverage in children, adolescents and adults is still unsatisfying. This situation is mainly due to inadequate remuneration of vaccination services, structural deficits in the health care system and a lack of motivation. Political support and leadership would most likely be able to change this situation.

medicine.medical_specialtyGeneral VeterinaryGeneral Immunology and Microbiologybusiness.industryPublic healthVaccinationPublic Health Environmental and Occupational HealthVaccinationPoliticsInfectious DiseasesVaccination coverageEnvironmental healthGermanyEpidemiologyHealth careImmunologymedicineRemunerationMolecular MedicineHumansbusinessVaccine
researchProduct

Influence of spurious dilution and hyperglycemia on erythrocytes and platelets evaluated with two different hematological analyzers

2015

The integrity of whole blood samples may be compromised by suboptimal collection practices. Therefore, we investigated the influence of spurious hyperglycemia on erythrocytes and platelets, assessed with two hematological analyzers using optical or impedance technique. Three K2EDTA blood specimens were collected from 12 healthy subjects, pooled and divided into four aliquots. The first aliquot was left untreated (glucose concentration 4.4 mmol/L), whereas scalar amounts of standard 5% glucose solution were added to the remaining, generating glucose contamination of 5% (19.2 mmol/L), 10% (33 mmol/L) and 20% (62 mmol/L). Hematological testing was then performed using Siemens Advia 2120 and Sy…

medicine.medical_specialtyHealth Toxicology and MutagenesisBiomedical EngineeringMean corpuscular hemoglobinHematocritGeneral Biochemistry Genetics and Molecular BiologyArtificial IntelligenceInternal medicinemedicinehyperglycaemia erythrocytes plateletsPlateletGeneral Pharmacology Toxicology and PharmaceuticsMean platelet volumeWhole bloodGeneral Immunology and Microbiologymedicine.diagnostic_testMean corpuscular hemoglobin concentrationChemistryGeneral NeuroscienceRed blood cell distribution widthGeneral MedicineEndocrinologyImmunologyplateletserythrocytesHemoglobinGeneral Agricultural and Biological Scienceshyperglycaemia
researchProduct

Treatment Persistence and Safety of Apremilast in Psoriasis: Experience With 30 Patients in Routine Clinical Practice

2020

Apremilast is a phosphodiesterase-4 inhibitor taken orally. Little information about its use in routine clinical practice is available. We aimed to assess treatment safety and persistence rates in patients on apremilast for different forms of plaque psoriasis. This observational retrospective study included 30 patients with psoriasis who were treated with apremilast between January 2016 and December 2017 in our hospital. Twelve patients had palmar-plantar psoriasis, 8 had plaque psoriasis mainly on the scalp, and 10 had plaque psoriasis in other locations. The probable period of treatment persistence in patients in the 50th percentile was 18.5 months according to survival analysis of the se…

medicine.medical_specialtyHistologybusiness.industryRetrospective cohort studyDermatologymedicine.diseaseDermatologyPathology and Forensic Medicinebody regions030207 dermatology & venereal diseases03 medical and health sciences0302 clinical medicinemedicine.anatomical_structurePsoriasisScalpmedicineRoutine clinical practiceObservational studyApremilastbusinessAdverse effectSurvival analysis030215 immunologymedicine.drugActas Dermo-Sifiliográficas (English Edition)
researchProduct

Tocilizumab therapy for unresponsive pulmonary arterial hypertension in a patient with Takayasu arteritis

2016

A 46-year-old female Caucasian patient was referred to our unit with upper extremity claudication, dyspnoea [New York Heart Association (NYHA) Class III], and weight loss. On physical examination, ...

medicine.medical_specialtyHypertension PulmonaryAntibodieTakayasu arteritisImmunologyPhysical examinationClass iiiTakayasu ArteritiAntibodies Monoclonal HumanizedTocilizumab therapyNew york heart association03 medical and health sciences0302 clinical medicineAntibodies Monoclonal Humanized; Female; Humans; Hypertension Pulmonary; Middle Aged; Takayasu Arteritis; Immunology and Allergy; Rheumatology; Immunology; Medicine (all)RheumatologyWeight lossInternal medicineMonoclonalmedicineImmunology and AllergyHumanized030203 arthritis & rheumatologymedicine.diagnostic_testbusiness.industryMedicine (all)General MedicinePulmonaryMiddle Agedmedicine.diseasePulmonary hypertensionSettore MED/16 - ReumatologiaHypertensionCardiologyFemalemedicine.symptomClaudicationbusiness030217 neurology & neurosurgeryHuman
researchProduct

Arterial thrombosis in Philadelphia-negative myeloproliferative neoplasms predicts second cancer: a case-control study.

2020

Abstract Patients with Philadelphia-negative myeloproliferative neoplasm (MPN) are prone to the development of second cancers, but the factors associated with these events have been poorly explored. In an international nested case-control study, we recruited 647 patients with carcinoma, nonmelanoma skin cancer, hematological second cancer, and melanoma diagnosed concurrently or after MPN diagnosis. Up to 3 control patients without a history of cancer and matched with each case for center, sex, age at MPN diagnosis, date of diagnosis, and MPN disease duration were included (n = 1234). Cases were comparable to controls for MPN type, driver mutations and cardiovascular risk factors. The freque…

medicine.medical_specialtyImmunologyKaplan-Meier EstimateGene mutationBiochemistryGastroenterologyMyeloproliferative neoplasms03 medical and health sciences0302 clinical medicineSDG 3 - Good Health and Well-beingInternal medicineCarcinomaMedicineHumansPhiladelphia ChromosomeMyeloproliferative neoplasmMyeloproliferative Disordersbusiness.industryCase-control studyCancerfood and beveragesMyeloproliferative neoplasmssecond cancersarterial eventsNeoplasms Second PrimaryThrombosisCell BiologyHematologyOdds ratioArteriesmedicine.diseasesecond cancersThrombosisSettore MED/15 - MALATTIE DEL SANGUEarterial events030220 oncology & carcinogenesisCase-Control StudiesMultivariate Analysis/dk/atira/pure/sustainabledevelopmentgoals/good_health_and_well_beingSkin cancerbusiness030215 immunologyFollow-Up StudiesBlood
researchProduct

Ibrutinib As Treatment for Chemoimmunotherapy-Resistant Patients with Follicular Lymphoma: First Results from the Open-Label, Multicenter, Phase 2 DA…

2016

Abstract Background: While first line therapy for FL with chemotherapy or chemoimmunotherapy produces durable responses, most patients (pts) with FL eventually relapse. Those who become resistant to chemoimmunotherapy have limited treatment options. Ibrutinib, an inhibitor of BTK (Bruton's tyrosine kinase) and ITK (interleukin-2-inducible T-cell kinase), has demonstrated robust clinical activity in various B-cell non-Hodgkin lymphomas. Previous Phase 1 and 2 studies have shown promising results with single-agent ibrutinib in pts with relapsed or refractory FL (Bartlett NL. Blood. 2014; 800 & Fowler N. Blood. 2015; 2706). The aim of the DAWN study was to provide additional efficacy and s…

medicine.medical_specialtyImmunologyPopulationFollicular lymphomaPhases of clinical researchBiochemistry03 medical and health scienceschemistry.chemical_compound0302 clinical medicineChemoimmunotherapyPartial responseInternal medicinemedicineeducationeducation.field_of_studybusiness.industryCell BiologyHematologymedicine.diseaseRegimenchemistry030220 oncology & carcinogenesisIbrutinibImmunologybusinessProgressive disease030215 immunologyBlood
researchProduct

Efficacy and Safety of Single-Agent Quizartinib (Q), a Potent and Selective FLT3 Inhibitor (FLT3i), in Patients (pts) with FLT3-Internal Tandem Dupli…

2018

Abstract Introduction: FLT3-ITD mutations are among the most common molecular abnormalities in AML, occurring in ≈ 25% of pts. These driver mutations are associated with high leukemic burden and poor prognosis, eg, high risk of relapse, decreased response to salvage therapy, and shorter overall survival (OS). Pts with R/R FLT3-ITD AML have a worse prognosis and represent a population with high unmet medical need. Q is a once-daily, oral, highly potent and selective FLT3i shown in phase 2 trials to have promising single-agent antileukemic activity and a manageable safety profile. QuANTUM-R was the first global, phase 3, randomized controlled trial (NCT02039726) to show that an FLT3i prolonge…

medicine.medical_specialtyImmunologyPopulationSalvage therapyBiochemistrylaw.invention03 medical and health scienceschemistry.chemical_compound0302 clinical medicineRandomized controlled triallawInternal medicinemedicineIn patienteducationQuizartinibeducation.field_of_studybusiness.industryCell BiologyHematologyTransplantationchemistry030220 oncology & carcinogenesisRelapsed refractorybusiness030215 immunologyFlt3 itdBlood
researchProduct

Idiopathic thrombotic thrombocytopenic purpura: strongest risk factor for relapse from remission is having had a relapse

2016

BACKGROUND Thrombotic thrombocytopenic purpura (TTP) is a rare, episodic clinical syndrome involving the production of thrombi in the microvasculature accompanied by thrombocytopenia and symptoms of organ ischemia. Idiopathic TTP develops when a patient produces antibodies that react with the protease ADAMTS13. The course after an episode is unpredictable; patients may relapse frequently or never. There is no laboratory value that can reliably predict potential relapse. STUDY DESIGN AND METHODS To assess diagnostic and predictive values for risk of relapse, plasma samples from 27 patients with idiopathic TTP in remission were analyzed for anti-ADAMTS13 immunoglobulin (Ig)G, ADAMTS13 activit…

medicine.medical_specialtyImmunologyThrombotic thrombocytopenic purpuraIschemiaDisease030204 cardiovascular system & hematologyBethesda unitGastroenterology03 medical and health sciences0302 clinical medicinehemic and lymphatic diseasesInternal medicineImmunology and AllergyMedicineRisk factorHematologybiologybusiness.industryHematologymedicine.diseaseADAMTS13Immunologybiology.proteinAntibodybusiness030215 immunologyTransfusion
researchProduct

Does adiponectin play a role in the pathogenesis of chronic spontaneous urticaria?

2020

Introduction Chronic spontaneous urticaria constitutes an interdisciplinary problem and its pathogenesis is still a subject of debate. Overweight and hyperlipidemia are supposed to be related to chronic spontaneous urticaria. Fatty tissue can be the source of adipokines. Aim of the study To assess the potential role of adiponectin in chronic spontaneous urticaria pathogenesis. Material and methods The study included 52 chronic spontaneous urticaria patients and 43 healthy controls. The patients were divided into two subgroups: patients with wheals only, and patients with urticaria and an accompanying angioedema. The adiponectin concentration was measured in all studied subjects. Results No …

medicine.medical_specialtyImmunologylcsh:MedicineAdipose tissueAdipokineOverweightGastroenterologychronic urticariaPathogenesisimmune system diseasesInternal medicineHyperlipidemiaparasitic diseasesmedicineImmunology and Allergyskin and connective tissue diseasesadipokinesAdiponectinAngioedemaadiponectinbusiness.industrypathogenesislcsh:RSignificant differencemedicine.diseaseClinical Immunologymedicine.symptombusinessmetabolismCentral-European Journal of Immunology
researchProduct